HIV Slides 14-27: Drugs Flashcards
What is the preferred regimen in HLAB5701 negative patients?
Dolutegravir (DTG) + Abacavir (ABC) + Lamivudine (3TC)
INSTI based
What is the preferred regimen in patients with CrCL over 30 mL/min but less than 70 mL/min?
Elvitegravir (EVG) + Cobicistat (C) + Tenofovir alafenamide (TAF) + Emtricitabine (FTC)
INSTI based
What is the preferred regimen in patients with CrCL over 70 mL/min?
Elvitegravir (EVG) + Cobicistat (C) + Tenofovir disoproxil fumarate (TDF) + Emtricitabine (FTC)
INSTI based
What is the only PI based regimen?
Ritonavir (R) boosted Darunavir (DRV) + Tenofovir disoproxil fumarate (TDF) + Emtricitabine (FTC)
What are the 2 INSTI based preferred regimens that aren’t specific to any patient population?
Dolutegravir (DTG) + Tenofovir alafenamide (TAF) + Emtricitabine (FTC)
Raltegravir (RAL) + Tenofovir disoproxil fumarate (TDF) + Emtricitabine (FTC)
What do all nucleoside analog inhibitors of reverse transcriptase have in common?
All require intracellular phosphorylation to be effective
What do all nonnucleoside reverse transcriptase inhibitors have in common?
They should not be used alone because of resistance development
Also they are not effective in HIV-2
Name the nucleoside analog inhibitors of reverse transcriptase (7)
Abacavir Didanosine Emtricitabine Lamivudine Stavudine Tenofovir Zidovudine
Name the nonnucleoside reverse transcriptase inhibitors?
Delavirdine Efavirenz - preferred agent! Etravirine Nevirapine Rilpivirine
Name the protease inhibitors
Atazanavir Darunavir Fosamprenavir Indinavir Lopinavir/Ritonavir boosted Nelfinavir Ritonavir (only used to boost other agents; potent inhibitor of CYP3A4) Saquinavir Tipranavir
Name the integrase inhibitors
Dolutegravir
Raltegravir
Elvitegravir (Only available co-formulated)
How does Maraviroc work?
CCR5 antagonist; receptors on CD4 cells exist as CCR5 or CXCR4 or mixture
Binding is necessary for fusion of viral and host membranes
As CD4 counts decrease, which receptor increases?
CXCR4
How does Enfuviritide work?
Blocks fusion of virus with T-cell membrane